Premium
Human bronchiolar epithelial cells functionally express P‐glycoprotein and multidrug resistance‐related protein‐1 (1064.11)
Author(s) -
Muchitsch Viktoria,
Gausterer Julia,
Salomon Johanna,
Ehrhardt Carsten
Publication year - 2014
Publication title -
the faseb journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.709
H-Index - 277
eISSN - 1530-6860
pISSN - 0892-6638
DOI - 10.1096/fasebj.28.1_supplement.1064.11
Subject(s) - efflux , p glycoprotein , atp binding cassette transporter , transporter , in vitro , multiple drug resistance , multidrug resistance associated protein 2 , chemistry , microbiology and biotechnology , multidrug resistance associated proteins , cell culture , confocal microscopy , in vivo , biochemistry , pharmacology , biology , gene , genetics , antibiotics
The human bronchiolar epithelial cell line, NCI‐H441 has recently been introduced as an in vitro model for studying drug disposition at the distal lung air‐blood barrier. Here, we determined levels of expression and function of major ATP‐binding cassette transporters, P‐glycoprotein (P‐gp) and multidrug resistance‐related protein‐1 (MRP1) in NCI‐H441 cells. P‐gp and MRP1 expression was quantified by immunoblot, whilst confocal laser scanning microscopy (CLSM) was employed to determine transporter localisation. Efflux experiments with rhodamin 123 (Rh123, P‐gp substrate) and 5,6‐carboxyfluorescein‐diacetate (CF, MRP1 substrate) were carried out assessing transporter function in vitro. Furthermore, the inhibitory effects of LY‐335979 (specific P‐gp inhibitor) and MK‐571 (specific MRP1 inhibitor) on Rh123 and CF efflux were investigated. Immunoblot provided evidence that NCI‐H441 cell monolayers expressed both efflux pumps on protein level. CLSM data confirmed these observations and moreover, revealed localisation of the transporters along apical membranes and in perimembranous vesicles. Rh123 and CF were both released from NCI‐H441 monolayers in a time‐dependent manner. This efflux could be inhibited by the relevant pharmacological agents.